2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
Equities are down this year because of Donald Trumps trade policies. The 47th U.S. president decided to impose steep tariffs…
92,830$
0,26%
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid:
Ask:
Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie
Astrazeneca Aktie: Details zum strategischen Plan
Trotz aktueller Schwächephase halten Analysten an Kaufempfehlungen fest - Dividendenankündigung und Quartalszahlen im Fokus. Die AstraZeneca-Aktie zeigt sich diese Woche…
The Zacks Analyst Blog AbbVies, Rinvoq and AstraZenecas and Novartis
AbbVies, Rinvoq and AstraZenecas and Novartis are included in this Analyst Blog.…
Result of AGM
11 April 2025
Results of Annual General Meeting held on 11 April 2025
AstraZeneca PLC announced the results of the voting at…
Gothenburg - a launch pad for health innovators
As the Nordic region’s largest healthcare market and a leading life science nation, Sweden is an attractive environment for healthtech…
Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs
The news of a likely import tariff hurt the share price of pharma giants like Novo Nordisk (NVO), Eli Lilly…
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Might the tariff risk for pharmaceutical stocks be less than you think?…
3 No-Brainer Growth Stocks to Buy for Less Than $100
Dont let the sell-off in the markets scare you off: Now may be an ideal time to buy stocks. Even…
Astrazeneca (AZN) Stock Moves -1.35%: What You Should Know
The latest trading day saw Astrazeneca (AZN) settling at $64.90, representing a -1.35% change from its previous close.…
AstraZenecas Innovation Ecosystem: From Blockbusters To The Next Generation Of Therapy
…
AstraZenecas metastatic breast cancer treatment gets EU nod
…
Imfinzi approved in EU for AEGEAN
04 April 2025
Imfinzi-based perioperative regimen approved in the EU for resectable non-small cell lung cancer
Approval based on AEGEAN Phase III trial…
Enhertu approved in EU in post-ET breast cancer
04 April 2025
Enhertu approved in the EU as first HER2-directed therapy for patients with HR-positive, HER2-low or HER2-ultralow metastatic breast cancer…
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Markets Swoon on Thursday
As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the…
UK pharma escapes worst of Trump tariffs (for now) but uncertainty may keep pressure on shares
International pharma stocks GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) may have dodged a bullet under Donald Trump’s sweeping new tariff...…